CB Insights
Technology Market Intelligence
Technology Market Intelligence
Clovis Oncology is developing cancer treatments for certain patients who have metastatic pancreatic cancer, non-small cell lung cancer, and various solid tumors. The Company is focused on licensing or acquiring rights to oncology compounds in all sta...Show all
Company (IPO / Went public)
Phone: 303-625-5000
5500 Flatiron Parkway
Boulder, 80301
Colorado, United States
| Total Funding | Date of Last Funding | |
|---|---|---|
| Clovis Oncology | $145M | Aug 16, 2019 |
| Corthera | $61M | Dec 23, 2009 |
| QuatRx Pharmaceuticals | $113.8M | May 22, 2007 |
| See all 15 competitors | ||
| Per Week | Per Month | Per 6 Months | Per Year | |
|---|---|---|---|---|
| Rank | Login to see details | |||
| Page Views Per Million | Login to see details | |||
| Page Views Per User | Login to see details | |||
| Reach Per Million | Login to see details | |||
| Title | Application Date | Patent Date | Status (Patent / Application) |
|---|---|---|---|
| Process for the preparation of 6-(7-((1-aminocyclopropyl)methoxy)-6-methoxyquinolin-4-yloxy)-n-methyl-1-naphthamide and synthetic intermediates thereof | Mar 18, 2015 | May 17, 2016 | Patent |
| Process for the preparation of 6-(7-((1-aminocyclopropyl)methoxy)-6-methoxyquinolin-4-yloxy)-n-methyl-1-naphthamide and synthetic intermediates thereof | Dec 23, 2013 | Apr 21, 2015 | Patent |
| High dosage strength tablets of rucaparib | Aug 17, 2015 | Application | |
| Salts of an epidermal growth factor receptor kinase inhibitor | May 05, 2014 | Application |
